Vaccine News and Research

Latest Vaccine News and Research

Scientists investigate relevance of COVID-19 vaccine-mediated T cell immunity to SARS-CoV-2 variants

Researchers showed the significance of T cell-based immunity against the SARS-CoV-2 variants exhibiting evasion to antibody-centric immunity.

19 May 2022

Impact of COVID-19 second booster vaccine on all-cause death among older cohorts

Scientists illustrated that the second booster dose of the SARS-CoV-2 vaccinations lowered all-cause death in the long-term care home residents and those aged 80 years or older.

19 May 2022

sCPD9: a SARS-CoV-2 nasal vaccine candidate that may have superior efficacy

...

19 May 2022

New study helps to better understand re-infection rates and correlates of protection for SARS-CoV-2

By uniting research from 8 cohorts across the U.S., a group of researchers has accelerated collection of data integral in answering questions about immune responses needed for long lasting protection from SARS-CoV-2.

19 May 2022

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Researchers evaluated the humoral and T lymphocyte immune responses against SARS-CoV-2 variants of concern among mild COVID-19 convalescent patients in South Australia.

19 May 2022

Neutralizing antibody responses induced by COVID-19 vaccines against SARS-CoV-2 variants

In a new study, researchers evaluated the ability of vaccine-induced antibodies to recognize and neutralize various SARS-CoV-2 variants of concern in SARS-CoV-2-naive health care workers in the Netherlands.

19 May 2022

Study finds gender-based disparity in life-saving TXA treatment

Injured women are half as likely as men to receive the life-saving drug tranexamic acid (TXA) even though the treatment is equally effective regardless of sex, according to new research in the British Journal of Anaesthesia.

19 May 2022

This rural, red Southern County was a vaccine success story. Not anymore.

At a glance, it seemed like a Southern pandemic success story in a most unlikely place.

19 May 2022

Study explores polyfunctionality of BNT162b2 COVID-19 vaccine-induced memory T-cells

Researchers assessed the impact of the BNT162b2 SARS-CoV-2 vaccine-induced memory T cells on the SARS-CoV-2 Omicron variant.

19 May 2022

Immunity conferred by COVID-19 vaccines in solid organ transplant recipients

In a recent study posted to the medRxiv* preprint server, researchers estimated the humoral immunity imparted by the two/three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in solid organ transplant recipients (SOTRs).

18 May 2022

Study in India shows SARS-CoV-2 Omicron is evolving

In a recent study posted to the bioRxiv* pre-print server, researchers analyzed the whole-genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) collected from SARS-CoV-2-infected patients in Delhi, India, between June 2021 and March 2022.

18 May 2022

Recombinant protein vaccine stands up to SARS-CoV-2 variants

A study by researchers in Texas describes a mouse model in which a subunit vaccine with alum-CpG adjuvant was tested for its ability to induce a broadly neutralizing antibody response against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 May 2022

Should children be vaccinated against COVID-19?

A new study conducted examines issues surrounding children between the ages of five and 11 who are eligible for vaccination against SARS-CoV-2.

18 May 2022

Study explores lipid nanoparticles against SARS-CoV-2

Researchers assessed the efficiency of lipid nanoparticles against SARS-CoV-2.

18 May 2022

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

In a new study, researchers evaluated the BNT162b2 coronavirus disease 2019 mRNA vaccine (antigen)-specific immune response among myeloid dysplastic syndrome and chronic lymphocytic leukemia patients.

18 May 2022

Study explores neurologic complications in pediatric COVID-19 cases

Researchers evaluated neurologic complications in pediatric cases of COVID-19.

18 May 2022

Combined COVID-19 vaccination regimen found to induce more potent anti-SARS-CoV-2 antibodies

Researchers assessed the vaccine-induced humoral responses against SARS-CoV-2 post four different vaccination regimens comprising homologous and heterologous vaccine doses.

18 May 2022

How better ventilation can help ‘covid-proof’ your home

For two years, you beat the odds. You masked, kept your distance, got your shots.

18 May 2022

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Imugene Limited, a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors.

18 May 2022

Discovery of a potent SARS-CoV-2 RBD specific human monoclonal antibody

A recent article posted to the bioRxiv* preprint server demonstrated structural underpinnings of the neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants by 002-S21F2, an extensive SARS-CoV-2 neutralizing antibody.

18 May 2022

Vaccine News and Research

Latest Vaccine News and Research

Scientists investigate relevance of COVID-19 vaccine-mediated T cell immunity to SARS-CoV-2 variants

Impact of COVID-19 second booster vaccine on all-cause death among older cohorts

sCPD9: a SARS-CoV-2 nasal vaccine candidate that may have superior efficacy

New study helps to better understand re-infection rates and correlates of protection for SARS-CoV-2

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Neutralizing antibody responses induced by COVID-19 vaccines against SARS-CoV-2 variants

Study finds gender-based disparity in life-saving TXA treatment

This rural, red Southern County was a vaccine success story. Not anymore.

Study explores polyfunctionality of BNT162b2 COVID-19 vaccine-induced memory T-cells

Immunity conferred by COVID-19 vaccines in solid organ transplant recipients

Study in India shows SARS-CoV-2 Omicron is evolving

Recombinant protein vaccine stands up to SARS-CoV-2 variants

Should children be vaccinated against COVID-19?

Study explores lipid nanoparticles against SARS-CoV-2

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Study explores neurologic complications in pediatric COVID-19 cases

Combined COVID-19 vaccination regimen found to induce more potent anti-SARS-CoV-2 antibodies

How better ventilation can help ‘covid-proof’ your home

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Discovery of a potent SARS-CoV-2 RBD specific human monoclonal antibody

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in